AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Reagents Track Immune Response.
Beckman Coulter, Inc. (4300 N. Harbor Blvd., Fullerton, CA 92834- 3100; Tel: 714/871-4848, Fax: 714/773-8283) has introduced three, ready-to-use, major histocompatibility complex (MHC) Tetramer reagents that produce rapid results from whole blood samples. MHC Tetramers enable accurate quantitative analysis of specific cellular immune response in infectious diseases.
The ITAg MHC Tetramer CMV for Cytomegalovirus, iTAg MHC Tetramer EBV for the Epstein-Barr virus, and iTAg MHC Tetramer Influenza measure T cells, one of the body's critical immune responses in fighting disease. Unlike traditional tests, which can take up to 2 wk., the disease-specific MHC Tetramers produce …
-
- Major milestone reached in Beckman Coulter's cellular immune response...
-
News wire article from: Asia Africa Intelligence Wire
November 21, 2002
700+ words
-
- Press Release: Beckman Coulter and Merck & Co enter technology and supply...
-
News wire article from: Chemical Business Newsbase
January 10, 2002
700+ words
-
- Beckman Coulter announces new epitope discovery technology at 3rd Annual...
-
News wire article from: Asia Africa Intelligence Wire
April 9, 2003
700+ words
-
- Playing iTag, Redux: Beckman Coulter Immunomics releases MHC class II...
-
Magazine article from: The Scientist
Adams, Amy
February 10, 2003
700+ words
-
- Study Finds Promise For iTAg Technology.
-
Newspaper article from: High Tech Separations News
October 1, 2001
700+ words
